O60503 (ADCY9_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 116.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Adenylate cyclase type 9 EC=4.6.1.1 Alternative name(s): ATP pyrophosphate-lyase 9 Adenylate cyclase type IX Adenylyl cyclase 9 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1353 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May play a fundamental role in situations where fine interplay between intracellular calcium and cAMP determines the cellular function. May be a physiologically relevant docking site for calcineurin By similarity. |
| Catalytic activity | ATP = 3',5'-cyclic AMP + diphosphate. |
| Cofactor | Binds 2 magnesium ions per subunit. |
| Enzyme regulation | Insensitive to calcium/calmodulin, forskolin and somatostatin. Stimulated by beta-adrenergic receptor activation. |
| Subcellular location | |
| Tissue specificity | Expressed in multiple cells of the lung, with expression highest in airway smooth muscle. Ref.2 |
| Sequence similarities | Belongs to the adenylyl cyclase class-4/guanylyl cyclase family. Contains 2 guanylate cyclase domains. |
| Sequence caution | The sequence AAC24201.1 differs from that shown. Reason: Frameshift at position 1252. The sequence BAA25446.3 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1353 | 1353 | Adenylate cyclase type 9 | PRO_0000195708 | |||||
Regions | |||||||||
| Topological domain | 1 – 117 | 117 | Cytoplasmic Potential | ||||||
| Transmembrane | 118 – 138 | 21 | Helical; Potential | ||||||
| Topological domain | 139 – 141 | 3 | Extracellular Potential | ||||||
| Transmembrane | 142 – 162 | 21 | Helical; Potential | ||||||
| Topological domain | 163 – 171 | 9 | Cytoplasmic Potential | ||||||
| Transmembrane | 172 – 192 | 21 | Helical; Potential | ||||||
| Topological domain | 193 – 215 | 23 | Extracellular Potential | ||||||
| Transmembrane | 216 – 235 | 20 | Helical; Potential | ||||||
| Topological domain | 236 – 241 | 6 | Cytoplasmic Potential | ||||||
| Transmembrane | 242 – 259 | 18 | Helical; Potential | ||||||
| Topological domain | 260 – 280 | 21 | Extracellular Potential | ||||||
| Transmembrane | 281 – 301 | 21 | Helical; Potential | ||||||
| Topological domain | 302 – 786 | 485 | Cytoplasmic Potential | ||||||
| Transmembrane | 787 – 807 | 21 | Helical; Potential | ||||||
| Topological domain | 808 – 818 | 11 | Extracellular Potential | ||||||
| Transmembrane | 819 – 839 | 21 | Helical; Potential | ||||||
| Topological domain | 840 – 867 | 28 | Cytoplasmic Potential | ||||||
| Transmembrane | 868 – 888 | 21 | Helical; Potential | ||||||
| Topological domain | 889 – 891 | 3 | Extracellular Potential | ||||||
| Transmembrane | 892 – 912 | 21 | Helical; Potential | ||||||
| Topological domain | 913 – 920 | 8 | Cytoplasmic Potential | ||||||
| Transmembrane | 921 – 941 | 21 | Helical; Potential | ||||||
| Topological domain | 942 – 975 | 34 | Extracellular Potential | ||||||
| Transmembrane | 976 – 996 | 21 | Helical; Potential | ||||||
| Topological domain | 997 – 1353 | 357 | Cytoplasmic Potential | ||||||
| Domain | 394 – 521 | 128 | Guanylate cyclase 1 | ||||||
| Domain | 1058 – 1198 | 141 | Guanylate cyclase 2 | ||||||
Sites | |||||||||
| Metal binding | 399 | 1 | Magnesium 1 By similarity | ||||||
| Metal binding | 399 | 1 | Magnesium 2 By similarity | ||||||
| Metal binding | 400 | 1 | Magnesium 2; via carbonyl oxygen By similarity | ||||||
| Metal binding | 443 | 1 | Magnesium 1 By similarity | ||||||
| Metal binding | 443 | 1 | Magnesium 2 By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 608 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 610 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 1259 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 1307 | 1 | Phosphoserine Ref.12 | ||||||
| Glycosylation | 206 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 955 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 964 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 772 | 1 | I → M in 37.5% of the Asian population, in 30% of the Caucasian population and in 16.3% of the African-American population; reduced adenylyl cyclase activity in response to stimulation of the beta-adregnergic receptor by the agonists Mn(2+), isoproteronol and NaF; increased albuterol-stimulated adenylyl cyclase activity in the presence of corticosteroid. Ref.2 Ref.3 Corresponds to variant rs2230739 [ dbSNP | Ensembl ]. | VAR_023750 | |||||
Experimental info | |||||||||
| Sequence conflict | 493 | 1 | G → R in CAB65084. Ref.4 | ||||||
| Sequence conflict | 884 | 1 | V → A in CAB65084. Ref.4 | ||||||
| Sequence conflict | 1154 | 1 | N → S in CAB65084. Ref.4 | ||||||
| Sequence conflict | 1154 | 1 | N → S in BAA25446. Ref.6 | ||||||
| Sequence conflict | 1308 | 1 | P → R in CAB65084. Ref.4 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9)." Hacker B.M., Tomlinson J.E., Wayman G.A., Sultana R., Chan G., Villacres E., Disteche C., Storm D.R. Genomics 50:97-104(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Heart. |
| [2] | "An Ile to Met polymorphism in the catalytic domain of adenylyl cyclase type 9 confers reduced beta2-adrenergic receptor stimulation." Small K.M., Brown K.M., Theiss C.T., Seman C.A., Weiss S.T., Liggett S.B. Pharmacogenetics 13:535-541(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, VARIANT MET-772. |
| [3] | "Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways." Tantisira K.G., Small K.M., Litonjua A.A., Weiss S.T., Liggett S.B. Hum. Mol. Genet. 14:1671-1677(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT MET-772. |
| [4] | "Cloning and characterisation of human adenylyl cyclase IX: differential mRNA regulation and inhibition by Ca2+/calcineurin." Paterson J.M., Smith S.M., Simpson J., Grace O.C., Bell J.E., Antoni F.A. Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [5] | "Mutation screening, case control study and transmission disequilibrium analysis of adenylate cyclase type 9 (ADCY9) gene in functional psychoses." Toyota T., Yamada K., Meerabux J., Hattori E., Saito K., Yoshitsugu K., Shimizu H., Nankai M., Toru M., Detera-Wadleigh S.D., Yoshikawa T. Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [6] | "Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro." Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. DNA Res. 5:31-39(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [7] | "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones." Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T. DNA Res. 9:99-106(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SEQUENCE REVISION. |
| [8] | Ohara O., Nagase T., Kikuno R., Ishikawa K. Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION. |
| [9] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [10] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1259, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1307, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF036927 mRNA. Translation: AAC24201.1. Frameshift. DQ008441 mRNA. Translation: AAY27880.1. DQ005545 mRNA. Translation: AAY21237.1. AJ133123 mRNA. Translation: CAB65084.1. AY028959 AY028957 Genomic DNA. Translation: AAK29464.1.AB011092 mRNA. Translation: BAA25446.3. Different initiation. CH471112 Genomic DNA. Translation: EAW85331.1. CH471112 Genomic DNA. Translation: EAW85332.1. BC136657 mRNA. Translation: AAI36658.1. BC136658 mRNA. Translation: AAI36659.1. BC151207 mRNA. Translation: AAI51208.1. |
| IPI | IPI00030099. |
| RefSeq | NP_001107.2. NM_001116.3. |
| UniGene | Hs.391860. Hs.610484. |
3D structure databases | |
| ProteinModelPortal | O60503. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000294016. |
PTM databases | |
| PhosphoSite | O60503. |
Proteomic databases | |
| PaxDb | O60503. |
| PRIDE | O60503. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000294016; ENSP00000294016; ENSG00000162104. |
| GeneID | 115. |
| KEGG | hsa:115. |
| UCSC | uc002cvx.3. human. |
Organism-specific databases | |
| CTD | 115. |
| GeneCards | GC16M004003. |
| HGNC | HGNC:240. ADCY9. |
| HPA | HPA041328. HPA044225. |
| MIM | 603302. gene. |
| neXtProt | NX_O60503. |
| PharmGKB | PA30. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG2114. |
| HOVERGEN | HBG050459. |
| InParanoid | O60503. |
| KO | K08049. |
| OMA | HMRSKLI. |
| OrthoDB | EOG4CRKZB. |
| PhylomeDB | O60503. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | endothelinpathway. Endothelins. lysophospholipid_pathway. LPA receptor mediated events. lpa4_pathway. LPA4-mediated signaling events. |
| Reactome | REACT_111102. Signal Transduction. REACT_111217. Metabolism. REACT_116125. Disease. REACT_13685. Neuronal System. REACT_15518. Transmembrane transport of small molecules. REACT_6900. Immune System. |
Gene expression databases | |
| ArrayExpress | O60503. |
| Bgee | O60503. |
| CleanEx | HS_ADCY9. |
| Genevestigator | O60503. |
| GermOnline | ENSG00000162104. Homo sapiens. |
Family and domain databases | |
| Gene3D | 3.30.70.1230. 2 hits. |
| InterPro | IPR001054. A/G_cyclase. IPR018297. A/G_cyclase_CS. [Graphical view] |
| Pfam | PF00211. Guanylate_cyc. 2 hits. [Graphical view] |
| SMART | SM00044. CYCc. 2 hits. [Graphical view] |
| SUPFAM | SSF55073. A/G_cyclase. 2 hits. |
| PROSITE | PS00452. GUANYLATE_CYCLASE_1. 2 hits. PS50125. GUANYLATE_CYCLASE_2. 2 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | O60503. |
| ChEMBL | CHEMBL2655. |
| ChiTaRS | ADCY9. human. |
| GenomeRNAi | 115. |
| NextBio | 445. |
| SOURCE | Search... |
Entry information
| Entry name | ADCY9_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O60503 Secondary accession number(s): A7E2V5 Q9UGP2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
